This research article from Nature Cancer identifies a critical link between vascular health and the progression of cancer cachexia, the debilitating loss of muscle mass in cancer patients. Through various tumor models and human samples, the authors discovered that a reduction in muscle capillary density actually happens before visible muscle wasting occurs. The study pinpoints a specific biological pathway where tumors release a factor called activin A, which travels through the blood to suppress the protein PGC1α within the inner lining of blood vessels. This suppression causes endothelial dysfunction, leading to leaky vessels, inflammation, and eventual muscle cell death. Significantly, the researchers demonstrated that restoring endothelial PGC1α activity could preserve blood vessel integrity and protect muscle mass. These findings suggest that targeting the health of the circulatory system may offer a new therapeutic strategy for treating cancer-related wasting.

References:

• Kim Y M, Sanborn M A, Vijeth S, et al. Skeletal muscle endothelial dysfunction through the activin A–PGC1α axis drives progression of cancer cachexia[J]. Nature Cancer, 2025, 6(8): 1350-1369.